MAPT and dementia: BBB disruption has been associated with cognitive function, for example in the context of dementia in Alzheimer’s Disease where individuals with early cognitive dysfunction develop damage to the brain capillary network and BBB breakdown in the hippocampus irrespective to changes in amyloid β or tau biomarkers.